Ruby Bio utilizes a proprietary biomanufacturing platform that converts low-cost sugar into high-value, complex molecules using engineered yeast. This process yields biodegradable and non-toxic ingredients for personal care, food, and polymer applications. The company provides sustainable, performance-driven alternatives to petroleum-based chemicals and synthetic additives.
Funding
$5.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many industries rely on ingredients and compounds that are not biodegradable or are derived from unsustainable sources, contributing to environmental pollution and health concerns. The transition to sustainable alternatives can be challenging due to performance limitations and cost considerations.
Solution
Ruby Bio offers a biosynthesis platform that uses naturally occurring yeast to convert low-cost sugar into biodegradable and non-toxic molecules. This technology provides sustainable alternatives for various industries, including personal care, food and beverage, and industrial applications. Ruby Bio partners with companies to provide ingredients and compounds that enable a shift to full sustainability, optimizing performance to match specific application requirements. The company's proprietary yeasts and manufacturing processes enable high-purity products that are intrinsically non-toxic and biodegradable.
Target Audience
Ruby Bio's primary customers are companies in the personal care, food and beverage, and industrial sectors seeking sustainable and biodegradable ingredients for their products.
Features
- Proprietary biosynthesis platform utilizing naturally occurring yeast
- Conversion of low-cost sugar into high-value, biodegradable molecules
- Sustainable alternatives for personal care, food and beverage, and industrial applications
- High-purity products that are intrinsically non-toxic
- Optimization of performance to match specific application requirements
- Commercial scale-up of biosynthesis technology